PHK
ORIC icon

Point72 Hong Kong’s Oric Pharmaceuticals ORIC Stock Holding History

Point72 Hong Kong’s Portfolio ORIC Stock Details ORIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,432
Closed -$5K – 1258
2022
Q3 		$5K Buy
1,432
+1,322
+1,202% +$5.29K ﹤0.01% 1790
2022
Q2 		$0 Sell
110
-4,422
-98% -$17.6K ﹤0.01% 2304
2022
Q1 		$24K Buy
+4,532
New +$40.8K ﹤0.01% 1498
2021
Q3 		– Sell
-1,895
Closed -$34K – 2341
2021
Q2 		$34K Buy
+1,895
New +$41.5K ﹤0.01% 1549

Other funds holding ORIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.69B AUM 86.67% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $849M AUM 470.8% 1-Year Est. Return